UB Paderborn / Katalog / Suche / in CDI

The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort

Pediatric pulmonology, 2024-09, Vol.59 (9), p.2236-2246

2024

Volltextzugriff (PDF)

Nail Bed Injury Repair: Nail Plate Replacement Versus Non-replacement

Eplasty, 2024-06, Vol.24, p.e37

2024

Volltextzugriff (PDF)

Scaphoid Fractures Requiring Bone Graft: Does Graft Source Matter?

Eplasty, 2024-05, Vol.24, p.e28

2024

Volltextzugriff (PDF)

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Annals of oncology, 2024-05, Vol.35 (5), p.448-457

2024

Volltextzugriff (PDF)

DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues

Nature communications, 2024-04, Vol.15 (1), p.3110-3110, Article 3110

2024

Volltextzugriff (PDF)

Repeatability of 18 F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

EJNMMI research, 2024-03, Vol.14 (1), p.32

2024

Volltextzugriff (PDF)

Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

EJNMMI research, 2024-03, Vol.14 (1), p.32-11, Article 32

2024

Volltextzugriff (PDF)

A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children

Scandinavian journal of trauma, resuscitation and emergency medicine, 2024-03, Vol.32 (1), p.16-16, Article 16

2024

Volltextzugriff (PDF)

Assessing Utility of 24-Hour Ambulatory Blood Pressure Monitoring to Distinguish Pediatric Populations Presenting with Elevated Blood Pressure in Rhode Island

Rhode Island medical journal (2013), 2024-02, Vol.107 (2), p.30-35

2024

Volltextzugriff (PDF)

Percutaneous Juxtapedicular Cement Salvage of Failed Spinal Instrumentation? Institutional Experience and Cadaveric Biomechanical Study

Operative neurosurgery (Hagerstown, Md.), 2024-01, Vol.26 (1), p.38-45

2024

Volltextzugriff (PDF)

Higher subclinical cardiac fibrosis in South African youth with HIV: results from the CTAAC-heart study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

129O Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Annals of oncology, 2023-11, Vol.34, p.S1520-S1521

2023

Volltextzugriff (PDF)

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Annals of oncology, 2023-10, Vol.34, p.S1315-S1316

2023

Volltextzugriff (PDF)

206 IL-22 binding protein: a potential target for immunomodulation in cystic fibrosis

Journal of cystic fibrosis, 2023-10, Vol.22, p.S107-S107

2023

Volltextzugriff (PDF)

The burden of critical illness among adults in a Swedish region—a population-based point-prevalence study

European journal of medical research, 2023-09, Vol.28 (1), p.1-322, Article 322

2023

Volltextzugriff (PDF)

SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication

mBio, 2023-08, Vol.14 (4), p.e0100723-e0100723

2023

Volltextzugriff (PDF)

CO70 Matching Adjusted Indirect Comparison (MAIC) of Single Tremelimumab Regular Interval Durvalumab (STRIDE) Versus Atezolizumab with Bevacizumab (A+B) for the Treatment of Unresectable Hepatocellular Carcinoma (UHCC)

Value in health, 2023-06, Vol.26 (6), p.S27-S27

2023

Volltextzugriff (PDF)

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study

Annals of oncology, 2023-03, Vol.34 (3), p.262-274

2023

Volltextzugriff (PDF)

A1193 - Safety, tolerability, and duration of continued darolutamide treatment in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): ARAMIS Rollover Study (ROS)

European urology, 2023-02, Vol.83, p.S1725-S1726

2023

Volltextzugriff (PDF)

Safety, tolerability, and duration of continued darolutamide treatment in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): ARAMIS Rollover Study (ROS)

European urology, 2023-02, Vol.83, p.S1725-S1726

2023

Volltextzugriff (PDF)

Sentence Retrieval for Open-Ended Dialogue Using Dual Contextual Modeling

Advances in Information Retrieval, p.426-440

Volltextzugriff (PDF)

Design of a national patient-centred clinical pathway for sepsis in Sweden

Infectious diseases (London, England), 2023, Vol.ahead-of-print (ahead-of-print), p.1-9

2023

Volltextzugriff (PDF)

Craniovertebral Junction Instability in the Setting of Chiari Malformation

Neurosurgery clinics of North America, 2023-01, Vol.34 (1), p.131-142

2023

Volltextzugriff (PDF)

Presentation of the septic patient to the emergency department with respect to age and sex - a retrospective cross-sectional study

BMC emergency medicine, 2022-12, Vol.22 (1), p.205-205, Article 205

2022

Volltextzugriff (PDF)

Association between variables measured in the ambulance and in-hospital mortality among adult patients with and without infection: a prospective cohort study

BMC emergency medicine, 2022-11, Vol.22 (1), p.1-185, Article 185

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort

Nail Bed Injury Repair: Nail Plate Replacement Versus Non-replacement

Scaphoid Fractures Requiring Bone Graft: Does Graft Source Matter?

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues

Repeatability of 18 F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children

Assessing Utility of 24-Hour Ambulatory Blood Pressure Monitoring to Distinguish Pediatric Populations Presenting with Elevated Blood Pressure in Rhode Island

Percutaneous Juxtapedicular Cement Salvage of Failed Spinal Instrumentation? Institutional Experience and Cadaveric Biomechanical Study

Higher subclinical cardiac fibrosis in South African youth with HIV: results from the CTAAC-heart study

129O Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

206 IL-22 binding protein: a potential target for immunomodulation in cystic fibrosis

The burden of critical illness among adults in a Swedish region—a population-based point-prevalence study

SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication

CO70 Matching Adjusted Indirect Comparison (MAIC) of Single Tremelimumab Regular Interval Durvalumab (STRIDE) Versus Atezolizumab with Bevacizumab (A+B) for the Treatment of Unresectable Hepatocellular Carcinoma (UHCC)

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study

A1193 - Safety, tolerability, and duration of continued darolutamide treatment in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): ARAMIS Rollover Study (ROS)

Safety, tolerability, and duration of continued darolutamide treatment in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): ARAMIS Rollover Study (ROS)

Sentence Retrieval for Open-Ended Dialogue Using Dual Contextual Modeling

Design of a national patient-centred clinical pathway for sepsis in Sweden

Craniovertebral Junction Instability in the Setting of Chiari Malformation

Presentation of the septic patient to the emergency department with respect to age and sex - a retrospective cross-sectional study

Association between variables measured in the ambulance and in-hospital mortality among adult patients with and without infection: a prospective cohort study

Aktive Filter

Suchergebnisse filtern